Evidence map›Paper›PMID 24394186›Full record

ArticleMolecular therapy : the journal of the American Society of Gene Therapy2014

Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.

Lars Steinstraesser, Martin C Lam, Frank Jacobsen, Paolo E Porporato, Kiran Kumar Chereddy, Mustafa Becerikli, Ingo Stricker, Robert Ew Hancock, Marcus Lehnhardt, Pierre Sonveaux and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular therapy : the journal of the American Society of Gene Therapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial.Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society · 2021
    Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Application of pulsed electric field technology to skin engineering.Frontiers in bioengineering and biotechnology · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Neutrophil-derived cathelicidin promotes cerebral angiogenesis after ischemic stroke.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2023
    Article
  14. Review
  15. In vitro and in vivo correlation of skin and cellular responses to nucleic acid delivery.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Article
  16. The evolution of clinical guidelines for antimicrobial photodynamic therapy of skin.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2022
    Review
  17. Article
  18. 1α,25-dihydroxyvitamin DNanomedicine (London, England) · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Lars SteinstraesserDepartment of Plastic, Reconstructive and Aesthetic Surgery, Handsurgery, Evangelisches Krankenhaus Oldenburg, European Medical School, Oldenburg, Germany.
Martin C Lam1] Department of Plastic Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany [2] Louvain Drug Research Institute, Pharmaceutics and Drug Delivery, Université catholique de Louvain, Brussels, Belgium.
Frank JacobsenDepartment of Plastic Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Paolo E PorporatoInstitut de Recherches Experimentales et Cliniques, Pole of Pharmacology, Université catholique de Louvain, Brussels, Belgium.
Kiran Kumar ChereddyLouvain Drug Research Institute, Pharmaceutics and Drug Delivery, Université catholique de Louvain, Brussels, Belgium.
Mustafa BecerikliDepartment of Plastic Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Ingo StrickerInstitute of Pathology, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Robert Ew HancockDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
Marcus LehnhardtDepartment of Plastic Surgery, Burn Center, BG University Hospital Bergmannsheil, Ruhr University Bochum, Bochum, Germany.
Pierre SonveauxInstitut de Recherches Experimentales et Cliniques, Pole of Pharmacology, Université catholique de Louvain, Brussels, Belgium.
Véronique PréatLouvain Drug Research Institute, Pharmaceutics and Drug Delivery, Université catholique de Louvain, Brussels, Belgium.
Gaëlle VandermeulenLouvain Drug Research Institute, Pharmaceutics and Drug Delivery, Université catholique de Louvain, Brussels, Belgium.
UCLouvain · BEBG University Hospital Bergmannsheil Bochum · DEEvangelisches Krankenhaus Oldenburg · DERuhr University Bochum · DEUniversity of British Columbia · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Host defense peptides, in particular LL-37, are emerging as potential therapeutics for promoting wound healing and inhibiting bacterial growth. However, effective delivery of the LL-37 peptide remains limiting. We hypothesized that skin-targeted electroporation of a plasmid encoding hCAP-18/LL-37 would promote the healing of wounds. The plasmid was efficiently delivered to full-thickness skin wounds by electroporation and it induced expression of LL-37 in the epithelium. It significantly accelerated reepithelialization of nondiabetic and diabetic wounds and caused a significant VEGFa and interleukin (IL)-6 induction. IL-6 was involved in LL-37-mediated keratinocyte migration in vitro and IL-6 neutralizing antibodies delivered to mice were able to suppress the wound healing activity of the hCAP-18/LL-37 plasmid. In a hindlimb ischemia model, electroporation of the hCAP-18/LL-37 plasmid increased blood perfusion, reduced muscular atrophy, and upregulated the angiogenic chemokines VEGFa and SDF-1a, and their receptors VEGF-R and CXCR-4. These findings demonstrate that a localized gene therapy with LL-37 is a promising approach for the treatment of wounds.

Indexed as

ElectrochemotherapyGenetic TherapyAnimalsAntimicrobial Cationic PeptidesCathelicidinsCells, CulturedHumansKeratinocytesMicePlasmidsWound HealingAntimicrobial Cationic PeptidesCathelicidins

Identifiers

PMID24394186
PMCPMC3982484
OpenAlexW2133709240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.